United Therapeutics founder Martine Rothblatt is counting on eVTOL aircraft to help her company move thousands of human organs to where they are needed to save lives through transplant surgery. Speaking at Aero Montreal’s International Aerospace Innovation Forum on December 15, the entrepreneur, who also founded the SiriusXM satellite radio network, said that the new generation of aircraft can deliver the operational flexibility needed to make large-scale organ transportation feasible.
Rothblatt explained that United Therapeutics has “three shots on goal” in its investment strategy in the eVTOL sector. First, it is the largest non-Chinese investor in EHang and its family of Autonomous Aerial Vehicles (AAVs). Second, it is backing U.S.-based Beta Technologies in its efforts to develop the Alia 250 aircraft. Finally, it is also backing Eco Helicopters in its project to develop an electrically powered version of the Robinson R44 light helicopter.
